Stefania Bortoluzzi

Prof. Stefania Bortoluzzi

Department of Molecular Medicine, University of Padova, 35122 Padova, Italy
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2003 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
CRChiara Romualdi
Chiara Romualdi
Stefania BortoluzziStefania Bortoluzzi
Stefania Bortoluzzi
FDFabio D’alessi
Fabio D’alessi
GDGian Antonio Danieli
Gian Antonio Danieli
Here we present a novel web tool for the statistical analysis of gene expression data in multiple tag sampling experiments. Differentially expressed genes are detected by using six different test statistics. Result tables, linked to the GenBank, UniGene, or LocusLink database, can be browsed or searched in different ways. Software is freely available at the site: http://telethon.bio.unipd.it/bioinfo/IDEG6_form/ , together with additional information on statistical methodologies.

10 December 2009 in Blood
Verified
Journal Article
Closed access
PDF file
MLMarta Lionetti
Marta Lionetti
MBMarta Biasiolo
Marta Biasiolo
Luca AgnelliLuca Agnelli
Luca Agnelli
KTKatia Todoerti
Katia Todoerti
LMLaura Mosca
Laura Mosca
Antonino NeriAntonino Neri
Antonino Neri
To date, little evidence of miRNA expression/deregulation in multiple myeloma has been reported. To characterize miRNA in the context of the major multiple myeloma molecular types, we generated miRNA expression profiles of highly purified malignant plasma cells from 40 primary tumors. Furthermore, transcriptional profiles, available for all patients, were used to investigate the occurrence of miRNA/predicted target mRNA pair anticorrelations, and the miRNA and genome-wide DNA data were integrated in a subset of patients to evaluate the influence of allelic imbalances on miRNA expression. Differential miRNA expression patterns were identified, which were mainly associated with the major IGH translocations; particularly, t(4;14) patients showed specific overexpression of let-7e, miR-125a-5p, and miR-99b belonging to a cluster at 19q13.33. The occurrence of other lesions (ie, 1q gain, 13q and 17p deletions, and hyperdiploidy) was slightly characterized by specific miRNA signatures. Furthermore, the occurrence of several allelic imbalances or loss of heterozygosity was found significantly associated with the altered expression of miRNAs located in the involved regions, such as let-7b at 22q13.31 or miR-140-3p at 16q22. Finally, the integrative analysis based on computational target prediction and miRNA/mRNA profiling defined a network of putative functional miRNA-target regulatory relations supported by expression data.

29 August 2013 in BMC Genomics
Verified
Journal Article
Open access
PDF file
SPSilvia Pizzini
Silvia Pizzini
ABAndrea Bisognin
Andrea Bisognin
Susanna MandruzzatoSusanna Mandruzzato
Susanna Mandruzzato
MBMarta Biasiolo
Marta Biasiolo
AFArianna Facciolli
Arianna Facciolli
PZPaola Zanovello
Paola Zanovello
Background: Qualitative alterations or abnormal expression of microRNAs (miRNAs) in colon cancer have mainly been demonstrated in primary tumors. Poorly overlapping sets of oncomiRs, tumor suppressor miRNAs and metastamiRs have been linked with distinct stages in the progression of colorectal cancer. To identify changes in both miRNA and gene expression levels among normal colon mucosa, primary tumor and liver metastasis samples, and to classify miRNAs into functional networks, in this work miRNA and gene expression profiles in 158 samples from 46 patients were analysed. Results: Most changes in miRNA and gene expression levels had already manifested in the primary tumors while these levels were almost stably maintained in the subsequent primary tumor-to-metastasis transition. In addition, comparing normal tissue, tumor and metastasis, we did not observe general impairment or any rise in miRNA biogenesis. While only few mRNAs were found to be differentially expressed between primary colorectal carcinoma and liver metastases, miRNA expression profiles can classify primary tumors and metastases well, including differential expression of miR-10b, miR-210 and miR-708. Of 82 miRNAs that were modulated during tumor progression, 22 were involved in EMT. qRT-PCR confirmed the down-regulation of miR-150 and miR-10b in both primary tumor and metastasis compared to normal mucosa and of miR-146a in metastases compared to primary tumor. The upregulation of miR-201 in metastasis compared both with normal and primary tumour was also confirmed. A preliminary survival analysis considering differentially expressed miRNAs suggested a possible link between miR-10b expression in metastasis and patient survival. By integrating miRNA and target gene expression data, we identified a combination of interconnected miRNAs, which are organized into sub-networks, including several regulatory relationships with differentially expressed genes. Key regulatory interactions were validated experimentally. Specific mixed circuits involving miRNAs and transcription factors were identified and deserve further investigation. The suppressor activity of miR-182 on ENTPD5 gene was identified for the first time and confirmed in an independent set of samples. Conclusions: Using a large dataset of CRC miRNA and gene expression profiles, we describe the interplay of miRNA groups in regulating gene expression, which in turn affects modulated pathways that are important for tumor development.

1 June 2013 in Immunity
Verified
Journal Article
Closed access
NSNada Sonda
Nada Sonda
FSFrancesca Simonato
Francesca Simonato
EPElisa Peranzoni
Elisa Peranzoni
BCBianca Calì
Bianca Calì
Stefania BortoluzziStefania Bortoluzzi
Stefania Bortoluzzi
VBVincenzo Bronte
Vincenzo Bronte

12 May 2011 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MMMassimo Milan
Massimo Milan
ACAlessandro Coppe
Alessandro Coppe
RRRichard Reinhardt
Richard Reinhardt
LCLeonor Cancela
Leonor Cancela
RLRicardo B. Leite
Ricardo B. Leite
LBLuca Bargelloni
Luca Bargelloni
The Manila clam, Ruditapes philippinarum, is one of the major aquaculture species in the world and a potential sentinel organism for monitoring the status of marine ecosystems. However, genomic resources for R. philippinarum are still extremely limited. Global analysis of gene expression profiles is increasingly used to evaluate the biological effects of various environmental stressors on aquatic animals under either artificial conditions or in the wild. Here, we report on the development of a transcriptomic platform for global gene expression profiling in the Manila clam.

19 May 2010 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
GSGabriele Sales
Gabriele Sales
ACAlessandro Coppe
Alessandro Coppe
ABAndrea Bisognin
Andrea Bisognin
MBMarta Biasiolo
Marta Biasiolo
Stefania BortoluzziStefania Bortoluzzi
Stefania Bortoluzzi
CRChiara Romualdi
Chiara Romualdi
MAGIA (miRNA and genes integrated analysis) is a novel web tool for the integrative analysis of target predictions, miRNA and gene expression data. MAGIA is divided into two parts: the query section allows the user to retrieve and browse updated miRNA target predictions computed with a number of different algorithms (PITA, miRanda and Target Scan) and Boolean combinations thereof. The analysis section comprises a multistep procedure for (i) direct integration through different functional measures (parametric and non-parametric correlation indexes, a variational Bayesian model, mutual information and a meta-analysis approach based on P-value combination) of mRNA and miRNA expression data, (ii) construction of bipartite regulatory network of the best miRNA and mRNA putative interactions and (iii) retrieval of information available in several public databases of genes, miRNAs and diseases and via scientific literature text-mining. MAGIA is freely available for Academic users at http://gencomp.bio.unipd.it/magia.